Concise review: Insights from normal bone remodeling and stem cell-based therapies for bone repair

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

There is growing interest in the use of mesenchymal stem cells for bone repair. As a major reason for normal bone remodeling is the removal of fatigue microcracks, advances in our understanding of this process may inform approaches to enhance fracture healing. Increasing evidence now indicates that physiological bone remodeling occurs in close proximity to blood vessels and that these vessels carry perivascular stem cells that differentiate into osteoblasts. Similarly, fracture healing is critically dependent on the ingrowth of blood vessels not only for a nutrient supply but also for the influx of osteoblasts. A number of animal and human studies have now shown the potential benefit of bone marrow-derived mesenchymal stem cells in enhancing bone repair. However, as in other tissues, the question of whether these cells improve fracture healing directly by differentiating into osteoblasts or indirectly by secreting paracrine factors that recruit blood vessels and the accompanying perivascular stem cells remains a major unresolved issue. Moreover, CD34+ cells, which are enriched for endothelial/ hematopoietic cells, have also shown efficacy in various bone repair models, at least in part due to the induction of angiogenesis and recruitment of host progenitor cells. Thus, mesenchymal and nonmesenchymal stem/progenitor cells are attractive options for bone repair. It is possible that they contribute directly to bone repair, but it is also likely that they express paracrine factors in the appropriate amounts and combinations that promote and sustain the healing process.

Original languageEnglish (US)
Pages (from-to)2124-2128
Number of pages5
JournalStem Cells
Volume28
Issue number12
DOIs
StatePublished - Dec 2010

Fingerprint

Bone Remodeling
Cell- and Tissue-Based Therapy
Stem Cells
Fracture Healing
Bone and Bones
Osteoblasts
Blood Vessels
Mesenchymal Stromal Cells
Fatigue
Endothelial Cells
Bone Marrow
Food

Keywords

  • Bone
  • Bone remodeling
  • Endothelial progenitor cells
  • Fracture
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Medicine

Cite this

Concise review : Insights from normal bone remodeling and stem cell-based therapies for bone repair. / Khosla, Sundeep; Westendorf, Jennifer J; Mödder, Ulrike I.

In: Stem Cells, Vol. 28, No. 12, 12.2010, p. 2124-2128.

Research output: Contribution to journalArticle

@article{c5a8670154c64b22aa3b16bf1f595c22,
title = "Concise review: Insights from normal bone remodeling and stem cell-based therapies for bone repair",
abstract = "There is growing interest in the use of mesenchymal stem cells for bone repair. As a major reason for normal bone remodeling is the removal of fatigue microcracks, advances in our understanding of this process may inform approaches to enhance fracture healing. Increasing evidence now indicates that physiological bone remodeling occurs in close proximity to blood vessels and that these vessels carry perivascular stem cells that differentiate into osteoblasts. Similarly, fracture healing is critically dependent on the ingrowth of blood vessels not only for a nutrient supply but also for the influx of osteoblasts. A number of animal and human studies have now shown the potential benefit of bone marrow-derived mesenchymal stem cells in enhancing bone repair. However, as in other tissues, the question of whether these cells improve fracture healing directly by differentiating into osteoblasts or indirectly by secreting paracrine factors that recruit blood vessels and the accompanying perivascular stem cells remains a major unresolved issue. Moreover, CD34+ cells, which are enriched for endothelial/ hematopoietic cells, have also shown efficacy in various bone repair models, at least in part due to the induction of angiogenesis and recruitment of host progenitor cells. Thus, mesenchymal and nonmesenchymal stem/progenitor cells are attractive options for bone repair. It is possible that they contribute directly to bone repair, but it is also likely that they express paracrine factors in the appropriate amounts and combinations that promote and sustain the healing process.",
keywords = "Bone, Bone remodeling, Endothelial progenitor cells, Fracture, Mesenchymal stem cells",
author = "Sundeep Khosla and Westendorf, {Jennifer J} and M{\"o}dder, {Ulrike I.}",
year = "2010",
month = "12",
doi = "10.1002/stem.546",
language = "English (US)",
volume = "28",
pages = "2124--2128",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Concise review

T2 - Insights from normal bone remodeling and stem cell-based therapies for bone repair

AU - Khosla, Sundeep

AU - Westendorf, Jennifer J

AU - Mödder, Ulrike I.

PY - 2010/12

Y1 - 2010/12

N2 - There is growing interest in the use of mesenchymal stem cells for bone repair. As a major reason for normal bone remodeling is the removal of fatigue microcracks, advances in our understanding of this process may inform approaches to enhance fracture healing. Increasing evidence now indicates that physiological bone remodeling occurs in close proximity to blood vessels and that these vessels carry perivascular stem cells that differentiate into osteoblasts. Similarly, fracture healing is critically dependent on the ingrowth of blood vessels not only for a nutrient supply but also for the influx of osteoblasts. A number of animal and human studies have now shown the potential benefit of bone marrow-derived mesenchymal stem cells in enhancing bone repair. However, as in other tissues, the question of whether these cells improve fracture healing directly by differentiating into osteoblasts or indirectly by secreting paracrine factors that recruit blood vessels and the accompanying perivascular stem cells remains a major unresolved issue. Moreover, CD34+ cells, which are enriched for endothelial/ hematopoietic cells, have also shown efficacy in various bone repair models, at least in part due to the induction of angiogenesis and recruitment of host progenitor cells. Thus, mesenchymal and nonmesenchymal stem/progenitor cells are attractive options for bone repair. It is possible that they contribute directly to bone repair, but it is also likely that they express paracrine factors in the appropriate amounts and combinations that promote and sustain the healing process.

AB - There is growing interest in the use of mesenchymal stem cells for bone repair. As a major reason for normal bone remodeling is the removal of fatigue microcracks, advances in our understanding of this process may inform approaches to enhance fracture healing. Increasing evidence now indicates that physiological bone remodeling occurs in close proximity to blood vessels and that these vessels carry perivascular stem cells that differentiate into osteoblasts. Similarly, fracture healing is critically dependent on the ingrowth of blood vessels not only for a nutrient supply but also for the influx of osteoblasts. A number of animal and human studies have now shown the potential benefit of bone marrow-derived mesenchymal stem cells in enhancing bone repair. However, as in other tissues, the question of whether these cells improve fracture healing directly by differentiating into osteoblasts or indirectly by secreting paracrine factors that recruit blood vessels and the accompanying perivascular stem cells remains a major unresolved issue. Moreover, CD34+ cells, which are enriched for endothelial/ hematopoietic cells, have also shown efficacy in various bone repair models, at least in part due to the induction of angiogenesis and recruitment of host progenitor cells. Thus, mesenchymal and nonmesenchymal stem/progenitor cells are attractive options for bone repair. It is possible that they contribute directly to bone repair, but it is also likely that they express paracrine factors in the appropriate amounts and combinations that promote and sustain the healing process.

KW - Bone

KW - Bone remodeling

KW - Endothelial progenitor cells

KW - Fracture

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=78651082309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651082309&partnerID=8YFLogxK

U2 - 10.1002/stem.546

DO - 10.1002/stem.546

M3 - Article

C2 - 20960512

AN - SCOPUS:78651082309

VL - 28

SP - 2124

EP - 2128

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 12

ER -